$Aslan Pharmaceuticals(ASLN.US)$Anticipated upcoming milestones •Late breaking poster presentation of positive translational data from a head-to-head study of eblasakimab versus dupilumab in a human tissue model of COPD at the American Thoracic Society International Conference 2024 on May 20, 2024 •Topline interim data from the farudodstat Phase 2a study in AA expected in Q3 2024•Topline data from the TREK-DX trial of eblasakimab expected at the end of 2024•Selection of a dev...
$Aslan Pharmaceuticals(ASLN.US)$ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
$Aslan Pharmaceuticals(ASLN.US)$Rare for me but i like so I averaged down a bit! Again i can do this because i scaled in some to begin with! Im not breaking my cost positioning to do it! NFA
Aslan Pharmaceuticals股票討論區
•Late breaking poster presentation of positive translational data from a head-to-head study of eblasakimab versus dupilumab in a human tissue model of COPD at the American Thoracic Society International Conference 2024 on May 20, 2024 •Topline interim data from the farudodstat Phase 2a study in AA expected in Q3 2024•Topline data from the TREK-DX trial of eblasakimab expected at the end of 2024•Selection of a dev...
Hi @Trytosaveabit May i kindly get ur opinion/ analysis on this company (No advise on buy sell).
暫無評論